Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Kerkhoff

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Anesthesia and Analgesia|June 27, 2018
Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective EvaluationInes Ellermann, Andreas Bueckmann, Maria Eveslage, et al.
JAMA Oncology|February 5, 2026
BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin LymphomaJustin Ferdinandus, Horst Müller, Janina Jablonski, et al.
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomasChristoph Schliemann, Teresa Hemmerle, Andrew F Berdel, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Plos One|May 23, 2018
Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 casesChristoph Schliemann, Andrea Kerkhoff, Paula Hesse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2022
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL TrialPaul J Bröckelmann, Ina Bühnen, Julia Meissner, et al.
Cancer Immunology Research|February 13, 2015
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantationChristoph Schliemann, Katrin L Gutbrodt, Andrea Kerkhoff, et al.
Haematologica|February 26, 2026
Anti-programmed cell death protein 1-based salvage therapy for relapsed/refractory Hodgkin lymphoma: a multicenter real-world analysisHishan Tharmaseelan, Lisa M Sgonina, Ina Bühnen, et al.
Blood Advances|June 10, 2026
Brentuximab Vedotin after AlloSCT for Relapsed/Refractory Hodgkin Lymphoma: GHSG BV-ALLO Phase II TrialChristof Scheid, Janina Jablonski, Andrea Kerkhoff, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Anesthesia and Analgesia|June 27, 2018
Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective EvaluationInes Ellermann, Andreas Bueckmann, Maria Eveslage, et al.
JAMA Oncology|February 5, 2026
BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin LymphomaJustin Ferdinandus, Horst Müller, Janina Jablonski, et al.
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomasChristoph Schliemann, Teresa Hemmerle, Andrew F Berdel, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Plos One|May 23, 2018
Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 casesChristoph Schliemann, Andrea Kerkhoff, Paula Hesse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2022
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL TrialPaul J Bröckelmann, Ina Bühnen, Julia Meissner, et al.
Cancer Immunology Research|February 13, 2015
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantationChristoph Schliemann, Katrin L Gutbrodt, Andrea Kerkhoff, et al.
Haematologica|February 26, 2026
Anti-programmed cell death protein 1-based salvage therapy for relapsed/refractory Hodgkin lymphoma: a multicenter real-world analysisHishan Tharmaseelan, Lisa M Sgonina, Ina Bühnen, et al.
Blood Advances|June 10, 2026
Brentuximab Vedotin after AlloSCT for Relapsed/Refractory Hodgkin Lymphoma: GHSG BV-ALLO Phase II TrialChristof Scheid, Janina Jablonski, Andrea Kerkhoff, et al.
Pageof 5